Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 10;17(12):1934.
doi: 10.3390/cancers17121934.

Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta-Analysis and Systematic Review of the Literature

Affiliations
Review

Multifocal Gastrointestinal Stromal Tumors (GISTs) of the Small Intestine in Patients with Neurofibromatosis Type 1 (NF-1): Meta-Analysis and Systematic Review of the Literature

Stylianos Mantalovas et al. Cancers (Basel). .

Abstract

Background/Objectives: The present investigation quantifies the striking predisposition for small intestinal GISTs in NF-1 patients, examining both multifocal and solitary tumor patterns while establishing critical epidemiological comparisons with the general population. By elucidating these distinct clinical and biological profiles, the study aims to transform the understanding of NF1-associated tumorigenesis and optimize patient surveillance strategies. Methods: This systematic review and meta-analysis was conducted in strict accordance with PRISMA guidelines, the gold-standard framework for minimizing bias and maximizing reproducibility in evidence synthesis. Prospectively registered in PROSPERO, the study employed a PICO framework to evaluate interventions, outcomes, and comparisons. Results: This systematic review and meta-analysis reveals a profound oncogenic propensity for small intestinal GISTs in NF-1 patients, demonstrating markedly increased prevalence relative to population baselines. The tumors display characteristic presentation and histological profiles, with a distribution of 54% multifocal lesions, 41% solitary SI-GIST, and 5% solitary duodenal GIST cases, demonstrating the diverse clinical manifestations of NF-1-associated tumors. These compelling findings not only redefine the epidemiological landscape of NF1-associated malignancies but also underscore extraordinary disease susceptibility, far surpassing previous estimates and sporadic occurrence rates in the general population. Conclusions: The distinct clinical patterns and high frequency of these tumors among NF-1 patients provide important insights into GIST development while underscoring the need for heightened clinical suspicion, particularly in patients manifesting gastrointestinal hemorrhage. These findings highlight the unique challenges in managing these cases-including diagnostic limitations and therapeutic constraints-underscoring the imperative for multidisciplinary therapeutic frameworks for detection, monitoring and treatment in this high-risk population.

Keywords: GIST; N-F1; multifocal; small intestine; solitary.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram [48].
Figure 2
Figure 2
ROBINS-E bias evaluation panel [52,53,54,55,56,57,58,59,60,61,62,63].
Figure 3
Figure 3
Percentage analysis of the bias-related questions’ assessments.
Figure 4
Figure 4
Multifocal small intestinal GIST resected during emergency surgery for acute intraluminal bleeding in an NF-1 patient (3rd Surgical Department, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki archive).
Figure 5
Figure 5
Dataset 1 forest plot [53,54,55,56,57,58,60,61,62,63].
Figure 6
Figure 6
Heterogeneity test and funnel plot interrogating dataset 1.
Figure 7
Figure 7
Dataset 2 forest plot [52,53,54,55,56,61,62,63].
Figure 8
Figure 8
Heterogeneity test and funnel plot interrogating dataset 2.
Figure 9
Figure 9
Dataset 3 forest plot [52,53,54,55,56,61,62,63].
Figure 10
Figure 10
Heterogeneity test and funnel plot interrogating dataset 3.
Figure 11
Figure 11
Dataset 4 forest plot [53,54,55,56,61,62,63].
Figure 12
Figure 12
Heterogeneity test and funnel plot interrogating dataset 4.
Figure 13
Figure 13
Dataset 5 forest plot [64,65,66,69,72,73,75,77,78,79,80,81,82,83,89].
Figure 14
Figure 14
Heterogeneity test and funnel plot interrogating dataset 5.
Figure 15
Figure 15
Beyond KIT/PDGFRA: the distinct molecular signature of the NF-1 tumor microenvironment in GIST pathobiology (SCF; Stem Cell Factor, VEGF; Vascular Endothelial Growth Factor, HIF1a; Hypoxia Inducible Factor 1a, PHD; Prolyl Hydroxylase Domain, GDP/GTP; Guanosine Diphosphate/Triphosphate, ETV1; ETS Variant transcription factor 1, MTOR; mammalian Target Of Rapamycin, TF; Transcription Factor).

References

    1. Radu P., Zurzu M., Paic V., Bratucu M., Garofil D., Tigora A., Georgescu V., Prunoiu V., Popa F., Surlin V., et al. Interstitial Cells of Cajal-Origin, Distribution and Relationship with Gastrointestinal Tumors. [(accessed on 17 March 2025)];Medicina. 2022 59:63. doi: 10.3390/medicina59010063. Available online: https://pubmed.ncbi.nlm.nih.gov/36676686/ - DOI - PMC - PubMed
    1. Niinuma T., Suzuki H., Sugai T. Molecular characterization and pathogenesis of gastrointestinal stromal tumor. [(accessed on 17 March 2025)];Transl. Gastroenterol. Hepatol. 2018 3:2. doi: 10.21037/tgh.2018.01.02. Available online: https://pubmed.ncbi.nlm.nih.gov/29441367/ - DOI - PMC - PubMed
    1. Unk M., Novaković B.J., Novaković S. Molecular Mechanisms of Gastrointestinal Stromal Tumors and Their Impact on Systemic Therapy Decision. [(accessed on 17 March 2025)];Cancers. 2023 15:1498. doi: 10.3390/cancers15051498. Available online: https://pubmed.ncbi.nlm.nih.gov/36900287/ - DOI - PMC - PubMed
    1. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., Kawano K., Hanada M., Kurata A., Takeda M., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. [(accessed on 17 March 2025)];Science. 1998 279:577–580. doi: 10.1126/science.279.5350.577. Available online: https://pubmed.ncbi.nlm.nih.gov/9438854/ - DOI - PubMed
    1. Serrano S., Broto J.M., Pascual J.M.A., Guerrero J.A.L., Casadevall J.R., Bague S., Muro X.G.D., Hernandez J.A.F., Herrero L., Pousa A.L., et al. 2023 GEIS Guidelinesfor gastrointestinal stromaltumors. [(accessed on 17 March 2025)];Ther. Adv. Med. Oncol. 2023 15:17588359231192388. doi: 10.1177/17588359231192388. Available online: https://pubmed.ncbi.nlm.nih.gov/37655207/ - DOI - PMC - PubMed

LinkOut - more resources